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Copyright © 2009 JCBN Summary Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] induces
heme oxygenase-1 (HO-1) expression via activation of the nuclear factor-erythroid-2-related
factor 2 (Nrf2), whereas tetrahydrocurcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-3,5-
heptanedione], one of curcumin in vivo metabolites, has no effect on HO-1 expression and Nrf2
activation. The aim of this study was to investigate whether dimethoxycurcumin [1,7-bis(4,3-
dimethoxyphenyl)-1,6-heptadiene-3,5-dione],  a synthetic curcumin analogue with higher
metabolic stability over curcumin, could induce HO-1 expression to the same extent as
curcumin in RAW264.7 macrophages. Dimethoxycurcumin and curcumin, but not tetra-
hydrocurcumin, induced HO-1 expression and Nrf2 nuclear translocation, suggesting that the
unsaturated nature of the diarylheptanoid chain of the compounds are crucial for HO-1
expression and Nrf2 activation. Blockage of Nrf2 synthesis by small interfering RNA abolished
HO-1 expression by dimethoxycurcumin, indicating that dimethoxycurcumin may induce
HO-1 expression via Nrf2 activation. In comparison, dimethoxycurcumin and curcumin had
about the same effect on HO-1 expression, suggesting that dimethoxycurcumin retains the
HO-1-inducing activity of its parent compound curcumin in RAW264.7 macrophages.
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Introduction
Heme oxygenase-1 (HO-1) that catalyzes the first and
rate-limiting step in the oxidative degradation of free heme
is now recognized as a fundamental endogenous cytoprotec-
tive system [1]. This enzyme can be expressed primarily by
its substrate, free heme, and also by a wide variety of endo-
genous and exogenous stimuli, suggesting that the molecular
mechanisms that regulate HO-1 expression are complex.
The nuclear factor-erythroid-2-related factor 2 (Nrf2) has
been shown to mediate HO-1 expression by certain phyto-
chemicals [2].
The dietary phytochemical curcumin (chemical structure
shown in Fig. 1) has a long history of medicinal use inS.-O. Jeong et al.
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India and Southeast Asia for a wide variety of medical
conditions [3]. Extensive investigations on the pharmaco-
logical activities of curcumin have demonstrated that
curcumin can induce HO-1 expression via Nrf2 activation
[4], thus being considered a non-cytotoxic HO-1 inducer.
Unfortunately, curcumin is rapidly metabolized in vivo into
tetrahydrocurcumin (THC; chemical structure shown in
Fig. 1) and other reduced forms [5]. Moreover, the anti-
inflammatory property of curcumin is lost when curcumin is
reduced to THC or others [6]. Thus, there is a need to
develop curcumin analogues with higher metabolic stability
than the original curcumin. Dimethoxycurcumin (DiMC;
chemical structure shown in Fig. 1), one of several synthetic
curcumin analogues, has been reported to exert an anticancer
activity comparable to curcumin and to have increased
metabolic stability in comparison with curcumin [7].
However, whether DiMC could exert other biological effects
similar to those of curcumin remains to be investigated.
Moreover, whether DiMC would induce HO-1 expression in
RAW264.7 macrophages is currently unknown, and was
thus investigated in this study.
Materials and Methods
Chemicals and reagents
Curcumin was isolated from the rhizomes of turmeric, as
described earlier [8]. THC was prepared from curcumin
by hydrogenating the two double bonds conjugated to the
β-diketone, as described previously [9]. DiMC was
synthetically prepared, as described previously [10], at the
College of Pharmacology, Wonkwang University (Iksan,
Republic of Korea). The purity of each compound, detected
by HPLC, was >90%. All solvents used in this study were
LC-MS grade and purchased from Sigma-Aldrich (St. Louis,
MO). Dulbecco’s modified Eagle’s medium (DMEM),
hemin, NADPH, glucose-6-phosphate dehydrogenase and 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide
(MTT) were purchased from Sigma-Aldrich. Antibodies
against HO-1, Nrf2 and β-actin were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). Nrf2 small inter-
fering RNA (siRNA) and its transfection kit were also from
Santa Cruz Biotechnology.
Cell culture and treatment
The mouse monocytic-macrophage cell line RAW264.7
(American Type Culture Collection, VA) was cultured in
DMEM containing 10% fetal bovine serum (Invitrogen,
Carlsbad, CA) and antibiotics (100 U/ml penicillin-G and
100 μg/ml streptomycin). Cultures were maintained at 37°C
in a humidified 5% CO2 atmosphere. RAW264.7 macro-
phages were cultured in either 6-well or 12-well flat-bottom
plates at the concentration of 5 × 105 cells/ml. After 12 h of
preconditioning, the cells were incubated with curcumin
analogues (1–10 μM).
Cell viability assay
Cell viability was determined by a modified MTT
reduction assay. MTT is a pale yellow substance that is
reduced by living cells to yield a dark blue formazan
product. This process requires active mitochondria, and
even fresh dead cells do not reduce significant amounts of
MTT. RAW264.7 macrophages were cultured in a 96-well
flat-bottom plate at concentration of 5 × 105 cells/ml. After
12 h of preconditioning, the cells were treated with various
concentrations of DiMC or other agents for 18 h. Thereafter,
culture medium was aspirated and 100 μl of MTT dye
(1 mg/ml in phosphate-buffered saline) was added; the
cultures were incubated for 4 h at 37°C. The formazan
crystals produced through dye reduction by viable cells
were dissolved using acidified isopropanol (0.1 N HCl).
Index of cell viability was calculated by measuring the
optical density of color produced by MTT dye reduction at
570 nm.
Heme oxygenase activity assay
Heme oxygenase activity was determined at the end of
each treatment as described previously [11]. Briefly,
harvested cells were subjected to three cycles of freeze-
thawing before addition to a reaction mixture consisting of
phosphate buffer (1 ml final volume, pH 7.4) containing
magnesium chloride (2 mM), NADPH (0.8 mM), glucose-6-
phosphate (2 mM), glucose-6-phosphate dehydrogenase (0.2
Units), rat liver cytosol as a source of biliverdin reductase,
and the substrate hemin (20 μM). The reaction mixture was
Fig. 1. Chemical structures of dimethoxycurcumin, curcumin
and tetrahydrocurcumin.DiMC Induces Nrf2-dependent HO-1 Expression
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incubated in the dark at 37°C for 1 h and was terminated by
the addition of 1 ml of chloroform. After being vigorously
vortexed and centrifuged, the extracted bilirubin in the
chloroform layer was measured by the difference in
absorbance between 464 and 530 nm (ε =4 0m M −1·cm−1).
Western blot analysis
RAW264.7 macrophages were incubated with or without
reagents. They were harvested, washed ice-cold phosphate-
buffered saline (PBS) and kept on ice for 1 min. The suspen-
sion was mixed with buffer A (10 mM HEPES, pH 7.5,
10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM DTT,
0.5 mM PMSF, 5 μg/ml aprotinin, 5 μg/ml pepstatin, and
10 μg/ml leupeptin) and lysed by three freeze-thaw cycles.
Cytosolic fraction was obtained by centrifugation at
12,000 × g for 20 min at 4°C. The pellets were re-suspended
in buffer C (20 mM HEPES, pH 7.5, 0.4 M NaCl, 1 mM
EGTA, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 5 μg/ml
aprotinin, 5 μg/ml pepstatin, and 10 μg/ml leupeptin) on ice
for 40 min and centrifuged at 14,000 × g for 20 min at 4°C.
The resulting supernatant was used as soluble nuclear
fraction. Protein content was determined with BCA protein
assay reagent (Pierce, Rockford, IL). Total cellular or nuclear
fractions were separated on 10% SDS-polyacrylamide gels,
and transferred to the nitrocellulose membranes (Amersham
Biosciences, Inc., Piscataway, NJ). The membrane was
then blocked in blocking buffer containing 20 mM sodium
phosphate buffer, pH 7.6, 150 mM NaCl, 0.1% Tween 20,
and 5% nonfat dry milk for 1 h at room temperature.
Thereafter, the membrane was incubated with antibodies
against HO-1 (1:1000 dilution), Nrf2 (1: 500 dilution) or
β-actin (1:1000 dilution) at 4°C overnight. The membrane
was then washed four times with PBS-Tween 20 buffer
and further incubated with secondary antibody for 1 h at
room temperature. Specific bands were detected using
enhanced chemiluminescence detection system (Amersham
Biosciences), and the membrane was exposed to X-ray film.
Nrf2 siRNA transfection
RAW264.7 macrophages were grown in 6- or 12-well
plates and transiently transfected with Nrf2 siRNA (Santa
Cruz Biotechnology) mixed with siRNA transfection
reagent (Santa Cruz Biotechnology) according to the manu-
facturer’s instructions. After incubation at 37°C and 5% CO2
for 30 h, cells were treated with DiMC and curcumin. The
samples were then prepared for Western blot analysis.
Statistical analysis
Data were analyzed using Student’s t test, one-way
analysis of variance or Newman-Keuls multiple comparison
test. Differences were considered significant when p<0.05.
Results
The chemical structures of curcumin analogues tested in
this study are shown in Fig. 1. While the original form of
curcumin contains two methoxy groups at two aromatic
rings, DiMC contains four. In comparison with curcumin,
THC contains two methoxy groups but lacks conjugated
double bonds in the central seven-carbon chain. Curcumin
and THC were used to explore possible mechanism(s) of
action of DiMC. In RAW264.7 macrophages, DiMC and
curcumin, but not THC, exhibited cytotoxicity at more than
20 μM (data not shown).
Treatment of RAW264.7 macrophages with different
concentrations of DiMC (2–10 μM) for 6 h resulted in a
significant increase in heme oxygenase activity (Fig. 2A);
this enzymatic activation was strongly associated with a
marked increase in HO-1 expression, as confirmed by
Western blot analysis (Fig. 2B). Similar to the effects
evoked by DiMC, treatment with curcumin resulted in a
substantial increase in heme oxygenase activity (Fig. 3A)
and HO-1 protein levels (Fig. 3B). In contrast, THC failed
to increase heme oxygenase activity and HO-1 expression
Fig. 2. Effects of DiMC on heme oxygenase activity and HO-1
expression in RAW264.7 macrophages. Cells were
treated with indicated concentrations of DiMC. (A) Heme
oxygenase activity was determined 6 h after exposure to
DiMC, as described in Materials and Methods. Bars
represent the means ± SD of 5–6 independent experi-
ments. *p<0.05 with respect to control (Con; open bar).
(B) HO-1 expression was detected 6 h after exposure to
DiMC, as described in Materials and Methods. Blots
shown are representative of 3 independent experiments.S.-O. Jeong et al.
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(Fig. 3).
In other experimental sets, we examined the effects of
DiMC and curcumin on Nrf2 activation in RAW264.7
macrophages, and found that both DiMC and curcumin
induced the nuclear accumulation of the transcription factor
Nrf2 (Fig. 4A). However, THC had no significant effect on
Nrf2 nuclear accumulation (not shown). The role of Nrf2 in
HO-1 expression by DiMC and curcumin was studied using
siRNA against Nrf2. As shown in Fig. 4B, transient trans-
fection with Nrf2 siRNA completely abolished HO-1 ex-
pression by DiMC as well as curcumin.
Discussion
As HO-1 is widely recognized as an effective cellular
strategy to counteract a variety of stressful events [12], the
induction of HO-1 by pharmacological modulators may
represent a novel target for therapeutic intervention. The
naturally occurring curcumin has been reported to induce
HO-1 expression [13–16], but whether DiMC, a modified
curcumin, could also induce HO-1 expression to the same
extent as the original form curcumin has not been investi-
gated so far. The present study demonstrates, for the first
time, that DiMC can induce HO-1 expression and Nrf2
activation in RAW264.7 macrophages.
The present study determined which structural features of
the DiMC molecule could contribute to its ability to serve as
an inducer of HO-1. For this purpose, we compared the
potency of DiMC and curcumin for HO-1 expression,
because DiMC is structurally related to curcumin. DiMC
affected the inducer potency only very slightly as compared
with that of curcumin (Fig. 3), suggesting that the substituted
methoxy groups in the DiMC are not essential for HO-1-
inducing activity. On the contrary, the α,β-unsaturated
carbonyl group may be an important structure of DiMC,
because THC, lacking this functional group, was virtually
inactive in inducing HO-1 expression. Compounds carrying
this reactive group have been reported to induce HO-1
expression through activation of Nrf2 nuclear translocation
[17, 18]. The cyclopentenone 15-deoxy-Δ12,14-prostaglandin
J2, possessing the α,β-unsaturated carbonyl group, has been
shown to induce HO-1 expression through Nrf2-dependent
pathway [19]. Moreover, curcumin which possesses two
α,β-unsaturated carbonyl groups has been already reported
to induce HO-1 expression by activating Nrf2 nuclear
translocation [15]. By structural analogy, DiMC can be
recognized to have a chemical property resembling that of
Fig. 3. Comparative effects of DiMC, curcumin and THC on
heme oxygenase activity and HO-1 expression in
RAW264.7 macrophages. Cells were treated with
indicated concentrations of DiMC, curcumin and THC.
(A) Heme oxygenase activity was determined 6 h after
exposure to different compounds, as described in
Materials and Methods. Bars represent the means ± SD
of 5–6 independent experiments. *p<0.05 with respect to
control (Con; open bar). (B) HO-1 expression was
detected 6 h after exposure to DiMC, as described in
Materials and Methods. Blots shown are representative
of 3 independent experiments.
Fig. 4. Effects of DiMC and curcumin on Nrf2 activation and
role of Nrf2 in HO-1 expression in RAW264.7 macro-
phages. (A) Cells were treated for indicated times with
5 µM of DiMC or curcumin. At each time point, nuclear
accumulation of Nrf2 protein was determined by
Western blot analysis, as described in Materials and
Methods. (B) Cells were transiently transfected with
Nrf2 siRNA, and then exposed to 5 µM of DiMC or
curcumin. HO-1 expression was detected 6 h after
exposure to the different compounds, as described in
Materials and Methods. Blots shown are representative
of 3 independent experiments.DiMC Induces Nrf2-dependent HO-1 Expression
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curcumin; this structural similarity prompted us to examine
whether DiMC could also activate Nrf2 nuclear trans-
location. Indeed, DiMC induced the activation of Nrf2
nuclear translocation, and this activation was obviously
associated with DiMC-induced HO-1 expression (Fig. 4B).
We, therefore, speculate that DiMC is effective in inducing
HO-1 expression, at least in part, because it bears the α,β-
unsaturated carbonyl group.
DiMC and curcumin were found to have about the same
effect at least partially on HO-1 expression in RAW264.7
macrophages; this may be because they have the same
functional group playing a crucial role in HO-1 expression.
Thus, our results confirm that DiMC, a synthetic curcumin
analogue with higher metabolic stability over curcumin [7],
retains the HO-1-inducing activity of its parent compound
curcumin.
Conclusion
The results of the present study demonstrate that: (i) the
synthetic DiMC induces HO-1 expression through Nrf2-
dependent pathway in RAW264.7 macrophages; (ii) the
α,β-unsaturated carbonyl group of DiMC are crucial for
Nrf2-dependent HO-1 expression; and (iii) the HO-1-
inducing activities of DiMC and curcumin are almost
identical.
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